FHIR 5.0.0 © HL7.org  |  FHIRsmith 0.8.5  |  Server Home  |  TX Home  |  Capability Statement  |  Terminology Capabilities  |  Operations  |  Problems  |   

TX: CodeSystem cvx

Properties

Defining URL http://hl7.org/fhir/sid/cvx
Version 20250715
Name CVX
Title CVX - US Vaccine Codes
Status active
Definition

CVX Codes for vaccines
Publisher Health Level 7

Properties

This code system defines the following properties for its concepts

Code Type Description
notes string Instructions on usage or other relevant notes.
vaccine-status code Indicates the availability of the vaccine in the United States.
non-vaccine boolean If 'true', this is not a product that is not a vaccine.
last-updated dateTime Indicates the last time this particular vaccine code was updated.

Filters

Code Description Op Value
vaccine-status Indicates the availability of the vaccine in the United States. = One of: 'active', 'inactive', 'pending', 'never-active', 'non-US'
non-vaccine If 'true', this is not a product that is not a vaccine. = 'false' (default) or 'true'

Concepts

This code system http://hl7.org/fhir/sid/cvx defines the following codes:

Code Display Instructions on usage or other relevant notes. Indicates the availability of the vaccine in the United States. If 'true', this is not a product that is not a vaccine. Indicates the last time this particular vaccine code was updated.
01 DTP Inactive false 2010-05-28
02 OPV, trivalent This is the OPV used in the US from June 1963 through Dec 1999 and globally through April 2016 Inactive false 2025-06-26
03 MMR Active false 2010-05-28
04 M/R Inactive false 2010-05-28
05 measles Inactive false 2010-08-31
06 rubella Inactive false 2015-06-18
07 mumps Inactive false 2015-06-18
08 Hep B, adolescent or pediatric This code applies to any standard pediatric formulation of Hepatitis B vaccine. It should not be used for the 2-dose hepatitis B schedule for adolescents (11-15 year olds). Use code 43 for that vaccine. Active false 2024-12-16
09 Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed Active false 2017-10-27
10 IPV Active false 2010-05-28
11 pertussis Inactive false 2010-05-28
12 diphtheria antitoxin Active true 2020-09-04
13 TIG Active true 2020-09-04
14 IG, unspecified formulation Inactive true 2023-03-09
15 influenza, split (incl. purified surface antigen) This code is being retired. It will still be found in older immunization records. It included both preservative free and non-preservative free. Inactive false 2010-09-30
16 influenza, whole Inactive false 2010-05-28
17 Hib, unspecified formulation Inactive false 2010-09-30
18 rabies, intramuscular injection This CVX code has been retired. It is replace by CVX 175, or CVX 176. It will continue to be found in historic records. Inactive false 2016-10-18
19 BCG Active false 2010-05-28
20 DTaP Active false 2010-05-28
21 varicella Active false 2010-05-28
22 DTP-Hib Inactive false 2017-03-23
23 plague Inactive false 2018-05-17
24 Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis Active false 2024-01-25
25 typhoid, oral Active false 2010-05-28
26 cholera, unspecified formulation Inactive false 2016-06-17
27 botulinum antitoxin Active true 2020-09-04
28 DT (pediatric) Retired effective 04/30/2023. All vaccine NDCs retired. No further vaccines expected for this formulation. Inactive false 2024-12-06
29 CMVIG Active true 2020-09-04
30 HBIG Active true 2020-09-04
31 Hep A, pediatric, unspecified formulation Do NOT use this code. If formulation is unknown, use CVX 85. There is only one formulation of Hep A, peds. Inactive false 2010-09-30
32 meningococcal MPSV4 Inactive false 2017-10-27
33 pneumococcal polysaccharide PPV23 Active false 2010-05-28
34 RIG Active true 2020-09-04
35 tetanus toxoid, adsorbed Inactive false 2015-08-14
36 VZIG Active true 2020-09-04
37 yellow fever live This is the YF vaccine that has been available in the US for years. It is stabilized with sorbitol and gelatin. Active false 2024-03-07
38 rubella/mumps Inactive false 2010-05-28
39 Japanese encephalitis SC Inactive false 2015-09-24
40 rabies, intradermal injection Inactive false 2015-06-18
41 typhoid, parenteral Inactive false 2015-08-13
42 Hep B, adolescent/high risk infant As of August 27, 1998, Merck ceased distribution of their adolescent/high risk infant hepatitis B vaccine dosage. Code 42 should only be used to record historical records. For current administration of hepatitis B vaccine, pediatric/adolescent dosage, use code 08. Inactive false 2010-05-28
43 Hep B, adult This code applies to any standard adult dose and schedule. Also use CVX 43 for the FDA approved Recombivax HB 2-dose hepatitis B schedule for adolescents (11-15 year olds) using the adult formulation. Active false 2024-12-12
44 Hep B, high-dosage, dialysis or IC This code is used record patient high dosage vaccine administration for dialysis or immunocompromised patients. For NDCs that are used for both regular vaccine and dialysis/IC high-dosage schedules (e.g. Engerix-B), are mapped to both CVX 43 and CVX 44. CVX code 44 should be utilized to record dialysis/IC dosing. Active false 2024-12-13
45 Hep B, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a HepB vaccination when noted on a vaccination card) Inactive false 2010-09-30
46 Hib (PRP-D) Inactive false 2010-05-28
47 Hib (HbOC) Inactive false 2010-05-28
48 Hib (PRP-T) Active false 2010-05-28
49 Hib (PRP-OMP) Active false 2010-05-28
50 DTaP-Hib Inactive false 2017-03-20
51 Hib-Hep B This vaccine may still be in use until the existing lots expire on 8/19/16. Inactive false 2016-03-11
52 Hep A, adult Active false 2010-05-28
53 typhoid, parenteral, AKD (U.S. military) Inactive false 2015-06-18
54 adenovirus, type 4 Inactive false 2010-05-28
55 adenovirus, type 7 Inactive false 2010-05-28
56 dengue fever tetravalent Applies to tetravalent product (e.g. DENGVAXIA) Active false 2024-12-11
57 hantavirus Never Active false 2020-09-09
58 Hep C Never Active false 2020-09-09
59 Hep E Never Active false 2020-09-09
60 herpes simplex 2 Never Active false 2020-09-09
61 HIV Never Active false 2020-09-09
62 HPV, quadrivalent Active false 2020-06-02
63 Junin virus Never Active false 2020-09-09
64 leishmaniasis Never Active false 2020-09-09
65 leprosy Never Active false 2020-09-09
66 Lyme disease Inactive false 2010-05-28
67 malaria Never Active false 2020-09-09
68 melanoma Never Active false 2020-09-09
69 parainfluenza-3 Inactive false 2025-01-09
70 Q fever Never Active false 2020-09-09
71 RSV-IGIV No active NDCs or CPT codes associated to this CVX Inactive true 2023-07-19
72 rheumatic fever Never Active false 2020-09-09
73 Rift Valley fever Never Active false 2020-09-09
74 rotavirus, tetravalent Inactive false 2010-05-28
75 Vaccinia (smallpox, mpox), live Active false 2025-04-30
76 Staphylococcus bacterio lysate Inactive true 2023-03-09
77 Tick-borne encephalitis vaccine (non-US) Non-US vaccine Non-US false 2022-03-04
78 tularemia vaccine Inactive false 2010-05-28
79 vaccinia immune globulin Active true 2020-09-04
80 VEE, live Inactive false 2010-05-28
81 VEE, inactivated Inactive false 2010-05-28
82 adenovirus, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a adenovirus vaccination when noted on a vaccination card) Inactive false 2010-09-30
83 Hep A, ped/adol, 2 dose Active false 2010-05-28
84 Hep A, ped/adol, 3 dose This vaccine formulation is inactive and should not be used, except to record historic vaccinations with this formulation. Inactive false 2010-05-28
85 Hep A, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a HepA vaccination when noted on a vaccination card) Inactive false 2010-09-30
86 IG Active true 2020-09-04
87 IGIV Active true 2020-09-04
88 influenza, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a Influenza vaccination when noted on a vaccination card) Inactive false 2010-09-30
89 polio, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a polio vaccination when noted on a vaccination card) Inactive false 2010-09-30
90 rabies, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a rabies vaccination when noted on a vaccination card) Inactive false 2010-09-30
91 typhoid, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a typhoid vaccination when noted on a vaccination card) Inactive false 2010-09-30
92 VEE, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a VEE vaccination when noted on a vaccination card) Inactive false 2010-09-30
93 RSV-MAb Active true 2020-09-04
94 MMRV Active false 2010-05-28
95 TST-OT tine test TB Skin test is not vaccine. Inactive true 2023-03-09
96 TST-PPD intradermal TB Skin test is not vaccine. Inactive true 2023-03-09
97 TST-PPD tine test TB Skin test is not vaccine. Inactive true 2023-03-09
98 TST, unspecified formulation TB Skin test is not vaccine. Inactive true 2023-03-09
99 RESERVED - do not use Code 99 will not be used in this table to avoid confusion with code 999. Inactive true 2020-09-09
100 pneumococcal conjugate PCV 7 Inactive false 2014-06-26
101 typhoid, ViCPs Active false 2010-05-28
102 DTP-Hib-Hep B This CVX has been corrected. This non-US vaccine contained DTP, Hib and Hep B. It was withdrawn in 2007 . Non-US false 2016-05-20
103 meningococcal C conjugate Inactive false 2010-05-28
104 Hep A-Hep B Active false 2010-05-28
105 vaccinia (smallpox) diluted Inactive false 2010-05-28
106 DTaP, 5 pertussis antigens Active false 2010-05-28
107 DTaP, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a DTaP vaccination when noted on a vaccination card) Inactive false 2010-09-30
108 meningococcal ACWY, unspecified formulation This CVX is intended for use when one of the meningococcal vaccines containing serogroups A, C, W and Y (conjugate or polysaccaride) was given and the exact formulation was not recorded. It should not be used to record newly administered immunizations. It is not to be used when one of the meningococcal vaccines containing other serogroups was administered. Inactive false 2015-12-01
109 pneumococcal, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a pneumococcal vaccination when noted on a vaccination card) Inactive false 2010-09-30
110 DTaP-Hep B-IPV Active false 2010-05-28
111 Influenza, live, trivalent, intranasal, PF HCP administered, trivalent code reactivated for 2024/2025 season Active false 2025-07-15
112 tetanus toxoid, unspecified formulation Inactive false 2010-09-30
113 Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed Active false 2024-01-25
114 meningococcal MCV4P Active false 2010-05-28
115 Tdap Active false 2010-05-28
116 rotavirus, pentavalent Active false 2010-05-28
117 VZIG (IND) Never Active true 2020-09-09
118 HPV, bivalent Inactive false 2010-05-28
119 rotavirus, monovalent Active false 2010-05-28
120 DTaP-Hib-IPV Active false 2010-05-28
121 zoster live Zostavax vaccine associated to this CVX Code retired 10/2022 Inactive false 2024-12-17
122 rotavirus, unspecified formulation Inactive false 2010-09-30
123 influenza, H5N1-1203 Inactive false 2010-05-28
125 Novel Influenza-H1N1-09, nasal Inactive false 2010-08-28
126 Novel influenza-H1N1-09, preservative-free Inactive false 2010-08-28
127 Novel influenza-H1N1-09 Inactive false 2010-08-28
128 Novel Influenza-H1N1-09, all formulations This code is used whenever the actual formulation is not determined or when aggregating all Novel H1N1 Influenza-09 immunizations for reporting to CRA. It should not be used for seasonal influenza vaccine that is not otherwise specified. (NOS) Inactive false 2010-08-28
129 Japanese Encephalitis, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a JE vaccination when noted on a vaccination card) Inactive false 2010-09-30
130 DTaP-IPV Active false 2010-05-28
131 typhus, historical Inactive false 2010-05-28
132 DTaP-IPV-HIB-HEP B, historical This is not the same as CVX 146, Hexavalent vaccine. Inactive false 2018-05-10
133 Pneumococcal conjugate PCV 13 Active false 2010-05-28
134 Japanese Encephalitis IM Active false 2010-05-28
135 Influenza, high-dose, trivalent, PF Trivalent code reactivated for 2024/2025 season Active false 2024-05-02
136 Meningococcal MCV4O Active false 2010-05-28
137 HPV, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a HPV vaccination when noted on a vaccination card) Inactive false 2010-09-30
138 Td (adult) Note that this Td is not adsorbed. Inactive false 2010-09-30
139 Td(adult) unspecified formulation This CVX code allows reporting of a historic vaccination when the formulation is unknown (for example, when recording a Td vaccination when noted on a vaccination card) Inactive false 2019-08-27
140 Influenza, split virus, trivalent, PF Trivalent code reactivated for 2024/2025 season Active false 2024-05-02
141 Influenza, split virus, trivalent, preservative Trivalent code reactivated for 2024/2025 season Active false 2024-05-02
142 tetanus toxoid, not adsorbed Inactive false 2015-08-14
143 Adenovirus types 4 and 7 This vaccine is administered as 2 tablets. Active false 2011-03-20
144 influenza, seasonal, intradermal, preservative free IIV3. No US product available since 2014/2015 flu season Inactive false 2022-12-15
145 RSV-MAb (new) Never Active true 2020-09-09
146 DTaP,IPV,Hib,HepB This vaccine is different from CVX 132. Code may be used to document non-US vaccines (e.g. Hexamin) of the same component formulation Active false 2022-08-10
147 meningococcal MCV4, unspecified formulation This CVX should only be used for historical doses of meningococcal conjugate vaccine where the formulation is unknown (oligosaccharide vs polysaccharide). It is not the same as CVX 108, Meningococcal, unspecified formulation. This CVX is for unspecified Meningococcal conjugate vaccines. Inactive false 2012-02-08
148 Meningococcal C/Y-HIB PRP Inactive false 2018-05-11
149 Influenza, live, quadrivalent, intranasal Quadrivalent code starting 2013/2014 season Active false 2024-05-15
150 Influenza, split virus, quadrivalent, PF Quadrivalent code starting 2013/2014 season Active false 2024-05-15
151 influenza nasal, unspecified formulation This CVX should only be used for historical records where the formulation of nasal flu vaccine is not known. Inactive false 2013-01-28
152 Pneumococcal Conjugate, unspecified formulation This CVX should only be used for historical records where the formulation of pneumococcal conjugate vaccine is not known. Inactive false 2013-01-28
153 Influenza, MDCK, trivalent, PF Trivalent code reactivated for 2024/2025 season Active false 2024-05-06
154 Hep A, IG Do not use this code. This product may be used for Hep A and other viral infections. The correct vaccine / CVX is 86 (IG). Never Active true 2020-09-09
155 Influenza, recombinant, trivalent, PF Trivalent code reactivated for 2024/2025 season Active false 2024-05-06
156 Rho(D)-IG This immune globulin may be administered either IM or IV. Active true 2020-09-04
157 Rho(D) -IG IM This immune globulin may be administered IM only. Active true 2020-09-04
158 Influenza, split virus, quadrivalent, preservative Quadrivalent code starting 2013/2014 season Active false 2024-05-15
159 Rho(D) - Unspecified formulation Inactive true 2023-03-09
160 Influenza A monovalent (H5N1), ADJUVANTED-2013 Approved by FDA 2013, adjuvant is mixed at point of administration. Active false 2014-05-27
161 Influenza, injectable,quadrivalent, preservative free, pediatric Active false 2024-07-29
162 meningococcal B, recombinant Active false 2014-11-03
163 meningococcal B, OMV Active false 2015-02-02
164 meningococcal B, unspecified Inactive false 2014-11-03
165 HPV9 Active false 2014-12-11
166 influenza, intradermal, quadrivalent, preservative free No US product available since 2017/2018 flu season Inactive false 2022-12-15
167 meningococcal, unknown serogroups This CVX is intended for use when any one of the meningococcal vaccines is recorded and there is no information about which serogroups are protected against. This code should not be used when a newly administered immunization is recorded. Inactive false 2015-12-01
168 Influenza, adjuvanted, trivalent, PF Trivalent code reactivated for 2024/2025 season Active false 2024-05-06
169 Hep A, live attenuated This vaccine is not available in the US. Non-US false 2016-05-10
170 DTAP/IPV/HIB - non-US This CVX was split off from CVX 102, to correctly identify the contents of the vaccine. Non-US false 2016-05-20
171 Influenza, MDCK, quadrivalent, PF Quadrivalent code starting 2016/2017 season Active false 2024-05-15
172 cholera, WC-rBS Non-US false 2016-06-17
173 cholera, BivWC Non-US false 2016-06-17
174 cholera, live attenuated Active false 2016-06-17
175 Rabies - IM Diploid cell culture Active false 2016-10-18
176 Rabies - IM fibroblast culture Active false 2016-10-18
177 PCV10 This is a foreign vaccine Non-US false 2016-12-19
178 OPV bivalent This is a non-US vaccine that may be seen in some immunization histories. Non-US false 2017-01-17
179 OPV ,monovalent, unspecified This is a non-US vaccine that may be seen in some immunization histories. It is composed of either Type 1, Type 2 or Type 3 oral polio vaccine. Non-US false 2017-01-17
180 tetanus immune globulin This record duplicates CVX 13 (TIG). Do not use CVX 180. Inactive true 2020-09-09
181 anthrax immune globulin Active true 2020-09-04
182 OPV, Unspecified This code represents an oral polio vaccine where the specific formulation is unknown. Inactive false 2017-01-17
183 Yellow fever vaccine live - alt This CVX is associated to an FDA unapproved drug to be used when there is a drug shortage. Stabilized with sorbitol and lactose and has been used outside the US for some time. Active false 2024-03-07
184 Yellow fever, unspecified Inactive false 2024-03-07
185 Influenza, recombinant, quadrivalent, PF Quadrivalent code starting 2017/2018 season Active false 2024-05-15
186 Influenza, MDCK, quadrivalent, preservative Quadrivalent code starting 2017/2018 season Active false 2024-05-15
187 zoster recombinant Active false 2017-10-27
188 zoster, unspecified formulation This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a zoster vaccination when noted on a vaccination card) Inactive false 2017-10-27
189 HepB-CpG Active false 2018-05-10
190 Typhoid conjugate vaccine (TCV) Non-US false 2023-01-17
191 meningococcal A polysaccharide (non-US) Non-US false 2018-05-10
192 meningococcal AC polysaccharide (non-US) Non-US false 2018-05-10
193 Hep A-Hep B, pediatric/adolescent e.g. Twinrix Junior available in Canada Non-US false 2018-08-21
194 Influenza, Southern Hemisphere This CVX code should be used to record administration of Southern Hemisphere influenza vaccine where formulation is unknown Inactive false 2020-07-16
195 DT, IPV adsorbed This code should be used to document non-US vaccines for DT,IPV such as Revaxis Non-US false 2023-01-17
196 Td, adsorbed, preservative free, adult use, Lf unspecified Used when Td Lf specification is unknown Active false 2019-08-15
197 Influenza, high-dose, quadrivalent, PF Quadrivalent code starting season 2020/2021 Active false 2024-05-15
198 DTP-hepB-Hib Pentavalent Non-US This represents the non-US pentavalent vaccine. Should be used for historic documentation in US Non-US false 2023-01-17
200 influenza, Southern Hemisphere, pediatric, preservative free Pediatric dose for ages 6-35 months Active false 2023-01-17
201 Influenza, Southern Hemisphere, quadrivalent, PF Represents single dose vial Active false 2025-04-22
202 influenza, Southern Hemisphere, quadrivalent, with preservative Represents multi-dose vial Active false 2023-01-17
203 meningococcal conjugate quadrivalent, MenACWY-TT (MCV4) Active false 2023-01-26
204 Ebola Zaire vaccine, live, recombinant, 1mL dose FDA Approved ERVEBO Vaccine. Active false 2024-01-03
205 Influenza, adjuvanted, quadrivalent, PF Quadrivalent code starting 2020/2021 season Active false 2024-05-15
206 Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection Associated to FDA US Licensed product JYNNEOS, non-US tradenames IMVANEX, IMVAMUNE. Review CDC & FDA guidance for updates regarding administration Active false 2023-02-14
207 COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose Original monovalent Moderna adult vaccine. FDA rescinded all doses for US use 4/18/2023. Continue to used to record historic US Moderna vaccines and those administered in non-US locations (includes tradename Spikevax) Inactive false 2023-10-24
208 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose Original monovalent Pfizer adult vaccine (12+ yrs). FDA rescinded all doses for US use 4/18/2023. Continue to use to record historic US Pfizer vaccines and Non-US vaccines administered (includes tradename Comirnaty) Inactive false 2023-11-14
210 COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL WHO authorized pandemic vaccine. Recognized towards immunity in US. AstraZeneca vaccine non-US WHO authorized tradenames/identifiers include VAXZEVRIA, AZD1222, ChAdOx1 nCoV-19, COVISHIELD Non-US false 2024-01-03
211 COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL Original monovalent Novavax vaccine (12+ years), FDA rescinded for US doses 10/03/2023. Continue to use to record Novavax Non-US vaccines administered (includes tradenames NUVAXOVID, COVOVAX) Inactive false 2023-10-24
212 COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL Original monovalent Janssen/J&J adult vaccine. All NDCs expired 6/20/2023, not reauthorized by FDA for Fall 2023 US doses. Continue to use to record Jansses/J&J Non-US vaccines administered vaccines administered Inactive false 2023-10-26
213 SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED Unspecified code for COVID-19 not to be used to record patient US administration. May be used to record historic US administration if product not known. CVX code 500 should be used to record Non-US vaccine where product is not known. Inactive false 2021-07-31
214 Ebola, unspecified Inactive false 2021-04-06
215 Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF Active 2021-08-18
216 Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF Active 2023-03-09
217 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose Original monovalent Pfizer tris-sucrose formulation FDA EUA (12+ yrs) and BLA (16+ yrs), FDA rescinded monovalent use 08/31/2022, BLA NDCs not retired until 09/11/2023. Inactive 2023-11-02
218 COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose Original monovalent Pfizer tris-sucrose formulation (5 yrs through 11 yrs), FDA rescinded 4/18/2023 Inactive 2023-10-25
219 COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose Original monovalent Pfizer tris-sucrose formulation (6 mo through 4 yrs), FDA rescinded 4/18/2023 Inactive 2023-10-26
220 HepB recombinant, 3-antigen, Al(OH)3 Manufacturer VBI has ceased operations - Prehevbrio Hep B vaccine voluntary recall effective 11/15/2024 Inactive 2024-12-11
221 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose Original monovalent Moderna, (Adult) FDA rescinded 4/18/2023, (6 yrs through 11 yrs) FDA rescinded 04/18/2023 Inactive 2023-10-25
222 Tick-borne encephalitis, unspecified Unspecified Code - should only be used when specific vaccine administered is unknown Inactive 2022-03-16
223 Tick-borne encephalitis, inactivated, PF, 0.25mL Pediatric dose vaccine Active 2022-03-03
224 Tick-borne encephalitis, inactivated, PF, 0.5mL Adult dose vaccine Active 2022-03-04
225 COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL EUA submission withdrawn by Sanofi Never Active 2023-03-09
226 COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL EUA submission withdrawn by Sanofi Never Active 2023-03-09
227 COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose Original monovalent Moderna pediatric vaccine (FDA rescinded 4/18/2023). Inactivated 6/14/2022 to use CVX code 221 product instead Inactive 2023-10-26
228 COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose Original monovalent Moderna pediatric vaccine (6 mo through 5 yrs), FDA rescinded 4/18/2023 Inactive 2023-10-27
229 COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose Original strain + omicron BA.4/BA.5 bivalent Moderna vaccine (6 mo and older), FDA rescinded 9/11/2023. Continue to use to record Non-US vaccines administered (tradename Spikevax Bivalent) Inactive 2023-10-26
230 COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL Original strain + omicron BA.4/BA.5 bivalent Moderna vaccine (6 mo through 5 yrs), FDA rescinded 9/11/2023 Inactive 2023-10-26
231 influenza, Southern Hemisphere, high-dose, quadrivalent Target population 65 and older, starting Southern Hemisphere season 2023 Active 2023-03-14
300 COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose Original strain + omicron BA.4/BA.5 bivalent Pfizer vaccine (12 yrs and older). FDA rescinded 09/11/2023. Continue to use to record Non-US vaccines administered (tradename Comirnaty Bivalent) Inactive 2023-10-26
301 COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose Original strain + omicron BA.4/BA.5 bivalent Pfizer vaccine (5 yrs through 11 yrs), FDA rescinded 9/11/2023 Inactive 2023-10-26
302 COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose Original strain + omicron BA.4/BA.5 bivalent Pfizer vaccine (6 mo through 4 yrs), FDA rescinded 09/11/2023 Inactive 2023-10-26
303 RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF Adults 60 years and older Active 2023-06-06
304 Respiratory syncytial virus (RSV), unspecified Unspecified, for historic records where it is not known if RSV vaccine or RSV MAB was administered Inactive 2024-01-03
305 RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF Adults 60 years and older, pregnant individuals Active 2024-08-07
306 RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months RSV monoclonal antibody (Beyfortus) Active 2023-07-25
307 RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months RSV monoclonal antibody (Beyfortus) Active 2023-08-09
308 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL Pfizer Fall Seasonal 6 months through 4 years of age Active 2024-08-30
309 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL Pfizer Fall Seasonal 12 years and older Active 2024-08-30
310 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL Pfizer Fall Seasonal 5 years through 11 years of age Active 2024-08-30
311 COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL Moderna Fall Seasonal 6 months through 11 years of age Active 2024-08-30
312 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL Moderna Fall Seasonal 12 years and older Active 2024-08-30
313 COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL Novavax Fall Seasonal 12 years and older Active 2024-09-05
314 Respiratory syncytial virus (RSV) vaccine, unspecified Unspecified, for historic records where the specific vaccine administered is not known Inactive 2023-09-19
315 Respiratory syncytial virus (RSV) MAB, unspecified Unspecified, for historic records where the specific RSV MAB administered is not known Inactive 2023-09-19
316 Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF Meningococcal pentavalent vaccine strains ABCW and Y Active 2024-01-25
317 Chikungunya live attenuated vaccine, 0.5 mL, PF Chikungunya Vaccine Active 2023-12-20
318 Anthrax, post-exposure prophylaxis National stockpile vaccine (Cyfendus) Active 2024-01-25
319 Anthrax vaccine, unspecified Unspecified code to record historic administration when specific product is unknown Inactive 2024-03-15
320 Influenza, MDCK, trivalent, preservative Trivalent code starting 2024/2025 season Active 2024-05-15
321 Influenza-avian, H5N8, monovalent, PF Novel Bird Flu H5N8 Vaccine 2024 Active 2024-06-12
322 Influenza-avian, H5N8, monovalent, preservative Novel Bird Flu H5N8 Vaccine 2024 Active 2024-06-12
323 Influenza-avian, H5, unspecified formulation Unspecified code H5xx vaccines to be used when specific formulation is unknown - for vaccines administered starting 2024 Inactive 2024-06-06
324 Poliovirus, inactivated, fractional-dose (fIPV) Non-US polio vaccine administered since 2016 Non-US 2024-06-05
325 Vaccinia (smallpox, mpox), unspecified Use this CVX for historical records where; the formulation administered is not known, or is a non-US product without an associated CVX code. Inactive 2025-05-02
326 RSV, mRNA, injectable, PF mRNA RSV vaccine added 2024 Active 2024-08-30
327 Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF Active 2024-07-11
328 Meningococcal oligosaccharide (MenACWY), (MenB), PF Meningococcal pentavalent vaccine strains ABCW and Y Active 2025-03-18
329 Chikungunya, VLP, recombinant, 0.8 mL, PF Active 2025-03-18
330 Dengue fever, unspecified Use this CVX for historical records where; the formulation of the dengue vaccine administered is not known, or is a non-US product without an associated CVX code. Inactive 2025-04-30
331 Influenza, Southern Hemisphere, trivalent, PF Represents single dose vial Active 2025-04-30
332 RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF RSV mAb for neonates and infants born during or entering first RSV season (Enflonsia) Active 2025-07-03
333 Influenza, live, trivalent, intranasal, self/caregiver admin, PF Self or caregiver administered, new starting 2025/2026 season Active 2025-07-15
500 COVID-19 Non-US Vaccine, Product Unknown Pandemic Non-US Covid Administration - specific CVX or product unknown Non-US 2021-07-15
501 COVID-19 IV Non-US Vaccine (QAZCOVID-IN) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Non-US 2021-07-15
502 COVID-19 IV Non-US Vaccine (COVAXIN) Pandemic Non-US Vaccine Authorized by WHO 11-3-2021, recognized toward immunity in US, https://extranet.who.int/pqweb/vaccines/who-recommendation-bharat-biotech-international-ltd-covid-19-vaccine-whole-virion Non-US 2021-11-19
503 COVID-19 LAV Non-US Vaccine (COVIVAC) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Non-US 2024-01-03
504 COVID-19 VVnr Non-US Vaccine (Sputnik Light) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Non-US 2021-07-15
505 COVID-19 VVnr Non-US Vaccine (Sputnik V) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Non-US 2021-07-15
506 COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology Pandemic Non-US Vaccine. Authorized by WHO 5/19/2022 - Counted toward immunity in US Non-US 2022-12-16
507 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Non-US 2021-08-18
508 COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Non-US 2024-01-03
509 COVID-19 PS Non-US Vaccine (EpiVacCorona) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Non-US 2021-07-15
510 COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) Pandemic Non-US Vaccine. Authorized by WHO - Counted toward immunity in US Non-US 2022-11-15
511 COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) Pandemic Non-US Vaccine. Authorized by WHO - Counted toward immunity in US Non-US 2022-11-15
512 SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) Pandemic Non-US Vaccine not Authorized by WHO - ACIP does recognize towards immunity in US Non-US 2022-04-12
513 SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Non-US 2022-04-12
514 SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Non-US 2022-04-12
515 SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Non-US 2022-04-12
516 COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Non-US 2022-04-12
517 SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Non-US 2022-04-12
518 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Non-US 2022-11-17
519 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna Pandemic Non-US Vaccine not Authorized by WHO - Is authorized by EU and counted toward immunity in US Non-US 2022-11-17
520 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech Pandemic Non-US Vaccine. Authorized by WHO 10/19/2022 - Counted toward immunity in US Non-US 2022-12-19
521 COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US Non-US 2024-01-03
801 AS03 Adjuvant This is the adjuvant that is packaged with H5N1 vaccine, adjuvanted Active true 2020-10-27
998 no vaccine administered Code 998 was added for use in VXU HL7 messages where the OBX segment is nested with the RXA segment, but the message does not contain information about a vaccine administration. An example of this use is to report the vaccines due next for a patient when no vaccine administration is being reported. Inactive true 2023-03-09
999 unknown This CVX code has little utility and should rarely be used. Inactive true 2020-10-27